Fernando Arroyo-Gonzalez, MD
Urology · Arecibo, PRNPI 1063947786
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,984 and has fallen 80.9% since, to $379 in 2025.
Across 24 payments — averaging $132.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Teleflex LLC$411
- Johnson & Johnson$237
- Ferring Pharmaceuticals Inc.$128
- Pfizer$85
- Olympus Latin America, Inc.$80
- plus $37 from 2 others
What the payments were for
- Travel & lodging$1,70053%
- Food & beverage$1,40144%
- Education$853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $2,208 |
| Teleflex LLC | 3 | $411 |
| Johnson & Johnson | 3 | $237 |
| Ferring Pharmaceuticals Inc. | 1 | $128 |
| Pfizer | 1 | $85 |
| Olympus Latin America, Inc. | 1 | $80 |
| Merck | 1 | $19 |
| PBG Puerto Rico LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GreenLight XPS$486
- UroLift$349
- AMS 700 CXR RTE KIT$130
- GENERAL KIDNEY STONE DISEASE$130
- ADSTILADRIN$128
- Erleada$125
- RYBREVANT$125
- AKEEGA$125
- Lumenis Pulse 120H$119
How this compares
$3,187 in reported general payments places this provider in the 60th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 304 | $24,455 |
| MyrbetriqMirabegron | 24 | $11,139 |
| Tolterodine Tartrate ErTolterodine Tartrate | 107 | $6,461 |
| Tamsulosin Hcl | 764 | $6,317 |
| Finasteride | 370 | $3,246 |
| Fosfomycin Tromethamine | 14 | $2,624 |
| Bicalutamide | 49 | $1,216 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $801 |
| Oxybutynin Chloride ErOxybutynin Chloride | 33 | $547 |
| Triamcinolone Acetonide | 44 | $382 |
| Levofloxacin | 69 | $373 |
| Ciprofloxacin Hcl | 62 | $359 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 29 | $332 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 63 | $222 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $168 |
Paid to pharmacies, not to this prescriber.
Other urology in Arecibo
- Victor Otano-RiveraArecibo$6K
- Raul ArroyoArecibo$4K
- Claudio Bernaschina BobadillaPonce$132K
- Mariela Martinez-RiveraPonce$105K
- Freddy Mendez TorresCayey$95K
- Luis AmbertRio Piedras$64K
- Jorge Crespo CarrilloRio Piedras$62K
- Ronald Cadillo ChavezBayamon$61K
- Andres Perez RomanSan Juan$58K
- Rafael Bouet BlasiniSan Juan$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.